Publications by authors named "Joe Budman"

Claim this Profile
D
Discovery of TD-0212, an Orally Active Dual Pharmacology AT Antagonist and Neprilysin Inhibitor (ARNI).
R Murray McKinnell, Paul Fatheree, Seok-Ki Choi, Roland Gendron, Keith Jendza, Joe Budman

ACS Med Chem Lett· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
Laxminarayan G Hegde, Cecile Yu, Travis Renner, Harold Thibodeaux, Scott R Armstrong, Joe Budman

J Cardiovasc Pharmacol· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Processing of DNA for nonhomologous end-joining is controlled by kinase activity and XRCC4/ligase IV.
Joe Budman, Sunny A Kim, Gilbert Chu

J Biol Chem· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assays for nonhomologous end joining in extracts.
Joe Budman, Gilbert Chu

Methods Enzymol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Processing of DNA for nonhomologous end-joining by cell-free extract.
Joe Budman, Gilbert Chu

EMBO J· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis